Akinetopsia is a rare neurological condition in which a person loses the ability to perceive visual motion. Instead of seeing the world in continuous, fluid movement, someone with akinetopsia sees objects frozen in place, then suddenly appearing somewhere else, as if life were a series of still photographs rather than a movie. The condition results from damage to a specific part of the visual cortex, and its rarity has made it both poorly understood by the public and deeply informative for neuroscientists trying to understand how the brain constructs our sense of a moving world.
What Akinetopsia Feels Like
The experience of akinetopsia is hard to convey to someone with normal vision, but patients have offered vivid descriptions. Imagine pouring coffee into a cup and seeing the liquid as a frozen, rising column of brown rather than a flowing stream. You would not be able to tell when the cup was about to overflow. Or picture crossing a street: cars are not approaching, they are simply in one spot, then suddenly in another, much closer spot, with no visible trajectory between the two positions. One patient famously described difficulty following conversations in a room because people’s mouths seemed to jump between positions rather than forming smooth speech movements.
The severity varies. In its most complete form, sometimes called “gross akinetopsia,” the world truly appears as a series of static snapshots. A milder version, sometimes called “fine akinetopsia” or the “cinematographic” form, is more like watching the world in very low frame rate. Motion is not entirely absent but appears jerky, stuttering, and broken into discrete steps. Some patients report seeing visual trails behind moving objects, similar to long-exposure photography, rather than perceiving coherent motion at all. A review of the condition describes it as “life in stop motion,” a phrase that captures the surreal disconnect patients feel between what they know is moving and what they actually see.
The Brain Region That Detects Motion
The human visual system does not process everything about a scene in one spot. Instead, different aspects of vision, like color, shape, depth, and motion, are handled by different specialized areas in the brain. Imaging research has identified two major visual processing streams: a ventral stream responsible for recognizing objects and forms, and a dorsal stream responsible for spatial awareness and motion perception.1PubMed Central. Ventral and dorsal streams processing visual motion perception (FDG-PET study) Akinetopsia arises when the motion-processing part of the dorsal stream is disrupted.
The critical area is called V5, also known as MT (for “middle temporal”). It sits in the lateral occipital and temporal cortex, roughly behind and above each ear. V5 is strongly activated by coherent motion, meaning patterns that move together in a way the brain can interpret as a single moving object or flow. In healthy people, activity in V5 rises as the coherence of a moving pattern increases. But when researchers tested what happens to V5 responses in patients who had lost primary visual cortex input, the normal positive relationship between motion coherence and V5 activity vanished entirely.2Brain. Motion area V5/MT+ response to global motion in the absence of V1 resembles early visual cortex V5 needs input from earlier visual areas to do its job properly. When that input is missing, motion perception breaks down.
Bilateral damage to V5 is the classic cause of full akinetopsia. In one well-studied patient, high-resolution brain scans confirmed that the zone normally occupied by V5 had been destroyed on both sides. Even so, brain imaging during exposure to moving stimuli showed that other regions, including parts of the parietal cortex and areas near V3, still responded to motion to some degree.3Oxford Academic (Brain). The brain activity related to residual motion vision in a patient with bilateral lesions of V5 These secondary activations help explain why some patients with V5 damage retain limited motion sensitivity rather than losing it completely.
The Patient Who Defined the Condition
Almost everything we know about akinetopsia in its complete form traces back to a single person, known in the literature as patient LM. In the early 1980s, LM suffered bilateral damage to V5 from a cerebrovascular event, and her case became one of the most extensively studied in all of neuroscience. Her published case provided what researchers called “compelling evidence for a selective and specific loss of movement vision.”4PubMed Central. The contribution of LM to the neuroscience of movement vision
LM’s deficit was remarkably selective. She could see colors, read text, recognize faces, and perceive depth. What she could not do was see things move. She described people in a room seeming to teleport from one position to another. Pouring tea was a genuine hazard because she could not gauge the rising liquid. Crossing streets became dangerous because approaching vehicles appeared to jump closer without any visible approach. Her case was pivotal because it showed that motion perception is not just a general feature of vision that degrades when the brain is injured. It is handled by a dedicated system that can be knocked out while leaving the rest of vision largely intact.
Interestingly, LM’s motion blindness was not absolute across every type of motion. She retained the ability to identify biological motion from point-light displays, the kind of sparse dot patterns that, when animated, give the impression of a walking human body. Because she could process this and had some residual motion ability, researchers tested whether she could also read lips. The results showed that some speechreading of faces was possible, suggesting that biological motion processing may rely on partially separate brain circuits from the ones destroyed in her injury.5Brain. Speechreading in the akinetopsic patient, L.M.
What Causes Akinetopsia
Stroke is the best-known trigger. A cerebrovascular event that damages V5 on both sides of the brain can produce lasting akinetopsia, as in patient LM’s case. But stroke is far from the only cause. A review of the condition notes that akinetopsia has also been linked to neurodegenerative disease and certain medications.6PubMed Central. Life in stop motion: a review of akinetopsia
Posterior cortical atrophy, a form of neurodegeneration that progressively damages the back of the brain, can produce akinetopsia as part of a broader breakdown of higher visual functions. This condition involves degeneration across the occipital, parietal, and posterior temporal lobes bilaterally, and its visual symptoms extend beyond motion blindness to include difficulty with reading, spatial orientation, and recognizing objects.7Frontiers in Neurology. Visual Dysfunction in Posterior Cortical Atrophy In posterior cortical atrophy, akinetopsia tends to appear alongside other visual losses, making it harder to isolate and study than the pure cases caused by focal brain lesions.
Epilepsy is another documented cause. One case involved a man who, at age 58, began experiencing episodes in which smooth movements of objects suddenly appeared as freeze frames, similar to a motion picture shown frame by frame. The episodes turned out to be epileptic seizures, and treatment with an anticonvulsant medication suppressed the akinetopsia completely.8PubMed Central. Akinetopsia as epileptic seizure This is a hopeful finding because it means that some forms of akinetopsia are treatable when the underlying cause is identified.
Drug-Induced Motion Blindness
Some medications can produce temporary akinetopsia as a side effect. The clearest documented examples involve nefazodone, an antidepressant. In one report, a 47-year-old man taking the drug at a standard dose noticed that moving objects were followed by a trail of multiple “freeze-frame” images that disappeared when the object stopped. A 48-year-old woman on a higher dose described the same trailing phenomenon. In both cases, the symptoms resolved when the medication was reduced or stopped.9PubMed. Akinetopsia from nefazodone toxicity
These drug-induced cases typically produce the milder, cinematographic form of akinetopsia rather than the complete loss of motion perception seen in patients with structural brain damage. The visual trailing effect, where a moving object leaves behind a series of ghostly afterimages, is characteristic. Nefazodone is rarely prescribed today, but the fact that a pharmaceutical agent can temporarily disrupt motion perception tells us something about how finely tuned the brain’s motion-processing chemistry is. Other medications, particularly those acting on serotonin pathways, have been anecdotally linked to similar visual disturbances, though the published evidence is thinnest outside the nefazodone cases.
Producing Akinetopsia in the Lab
One of the more striking pieces of evidence that V5 is genuinely the brain’s motion center comes from experiments in which researchers temporarily disabled it in healthy volunteers. Using transcranial magnetic stimulation, a technique that applies a brief magnetic pulse to a targeted brain area and temporarily disrupts its function, scientists showed that stimulation of a small region roughly one centimeter in diameter, corresponding to V5, could selectively and reversibly eliminate motion perception. Subjects reported that a moving target simply froze in place during the pulse.10PubMed. Cerebral visual motion blindness: transitory akinetopsia induced by transcranial magnetic stimulation of human area V5
The same study found a second, less dramatic interference with motion perception when the magnetic pulse was applied to V1, the primary visual cortex, at a specific timing window of 70 to 80 milliseconds after the onset of the visual stimulus. This suggests that motion processing depends on a relay: visual information hits V1 first, then gets forwarded to V5 for motion-specific analysis. Disrupting either station in the relay affects motion perception, but knocking out V5 has the more dramatic and specific effect. These experiments essentially created akinetopsia on demand, lasting only fractions of a second, and confirmed in living humans what lesion studies had already suggested.
The Riddoch Phenomenon and What It Tells Us
If akinetopsia is the inability to see motion despite otherwise functional vision, the Riddoch phenomenon is roughly its mirror image: the ability to see motion despite otherwise being blind. Patients with extensive damage to early visual cortex, including V1, can lose all awareness of stationary objects in their affected visual field while retaining a surprising ability to detect and respond to moving ones. One well-documented patient, known as MC, had extensive bilateral damage to occipitotemporal cortex that included most of her early visual cortex. Standard visual field testing with stationary targets showed complete blindness. Yet she could navigate through cluttered environments and even catch moving balls thrown toward her.11PubMed Central. Psychophysical and neuroimaging responses to moving stimuli in a patient with the Riddoch phenomenon due to bilateral visual cortex lesions
The Riddoch phenomenon matters for understanding akinetopsia because it reveals that motion processing has some degree of independence from the rest of visual processing. V5 can receive motion signals through pathways that bypass the damaged V1, allowing motion awareness to survive in the absence of form or detail vision. This is essentially the reverse of what happens in akinetopsia, where V5 is destroyed but V1 and the rest of the visual system remain functional. Together, these two conditions act as a double dissociation, providing strong evidence that motion perception is handled by a genuinely separate brain module rather than being just another aspect of general visual acuity.
Living With Akinetopsia
For people with the permanent, structural form of akinetopsia caused by bilateral V5 damage, daily life requires significant adaptation. Nearly every ordinary activity involves motion perception to some degree, often in ways you would never think about until it was gone. Pouring liquids, navigating crowds, judging the speed of traffic, reading a scrolling screen, watching facial expressions shift during a conversation, even tracking your own hand as you reach for a doorknob all depend on the brain’s motion system.
Patient LM, whose case has been followed for decades, developed coping strategies that relied heavily on inference rather than perception. She learned to judge that a cup was likely full by how long she had been pouring rather than by watching the liquid rise. She relied on auditory cues, like the sound of an approaching car’s engine, to compensate for her inability to see vehicles moving toward her. Social situations remained difficult because facial expressions, gestures, and mouth movements all appeared as disconnected snapshots rather than fluid communication.
There is no established treatment that restores motion perception when V5 has been structurally destroyed. Rehabilitation research in cortical vision loss more broadly tends to focus on training residual visual pathways and maximizing compensatory strategies. For the transient forms of akinetopsia caused by medications or seizures, the picture is far more optimistic. Removing the offending drug or treating the underlying epilepsy has resolved symptoms in documented cases. The distinction between permanent and treatable forms is crucial, and clinicians encountering a patient who describes freeze-frame vision or visual trailing should investigate reversible causes before assuming structural damage.
How Akinetopsia Challenges Simple Models of Vision
For most of us, seeing feels like a single, unified act. You open your eyes and the world is just there, complete with color, shape, depth, and motion all fused into one seamless experience. Akinetopsia demolishes that intuition. It shows that what feels like a single perception is actually assembled from multiple parallel processing streams, and those streams can be selectively broken.
One of the more puzzling findings involves a patient known as TD, who had akinetopsia but paradoxically experienced a version of the continuous wagon wheel illusion at fast speeds. This is the effect where a spinning wheel appears to reverse direction, an illusion that some researchers attribute to the brain sampling visual information in discrete snapshots rather than continuously. TD’s experience of this illusion, even with impaired fast-motion perception, suggests that surviving brain areas might operate at different temporal sampling rates than the damaged ones.12Cortex. The effect of target speed on perception of visual motion direction in a patient with akinetopsia This kind of finding complicates clean theoretical stories about how V5 works and pushes researchers toward more nuanced models in which multiple brain regions contribute to motion perception at different speeds and in different contexts.
The very rarity of akinetopsia has shaped how the condition is studied. With so few patients available worldwide who have the pure, bilateral V5 lesion form, the field has relied heavily on single-case studies and the TMS experiments that create fleeting akinetopsia in volunteers. This means that the scientific literature is unusually deep on a very small number of patients, particularly LM, and relatively thin on population-level data. Whether akinetopsia manifests identically across different individuals, different lesion geometries, and different etiologies remains an open question. As neurodegenerative causes like posterior cortical atrophy become better recognized, the pool of studied patients may slowly grow, but for now, akinetopsia remains one of those rare conditions where almost everything we know traces back to a handful of remarkable case reports.
When Motion Blindness Gets Mistaken for Something Else
Because akinetopsia is so rare, it is easily misdiagnosed or overlooked entirely. Patients who describe seeing “freeze frames” or “trailing images” may initially be evaluated for ocular problems, migraine aura, psychiatric conditions, or medication side effects without anyone considering a cortical motion deficit. The drug-induced cases illustrate this risk clearly. A person taking an antidepressant who suddenly sees trailing images behind moving objects might reasonably assume they are having a visual migraine or even a psychiatric symptom, and their physician might agree. Without awareness that akinetopsia exists as a distinct pharmacological side effect, the correct diagnosis could be missed for months.
Migraine aura, in particular, shares some superficial features with mild akinetopsia. Migraine aura can produce transient visual disturbances that include shimmering, zigzag patterns, and occasionally altered motion perception. But aura is typically brief, lasting 20 to 60 minutes, and comes packaged with other visual phenomena. Akinetopsia, even the drug-induced kind, tends to be persistent as long as the trigger is present and specifically affects motion without the kaleidoscopic visual effects of migraine. Hallucinogen persisting perception disorder, sometimes called “flashbacks,” can also produce visual trailing, but the patient history and clinical context are usually different.
For clinicians, the key clue is specificity. A patient whose sole complaint is that motion looks broken, with everything else about their vision functioning normally, is pointing toward a motion-processing deficit. Structural brain imaging focused on the lateral occipital and temporal cortex, combined with targeted motion-perception testing, can help distinguish true akinetopsia from conditions that mimic it. For patients, the practical takeaway is simpler: if you notice that moving things look like they are stuttering, leaving trails, or jumping from place to place, and the symptom is persistent rather than fleeting, it is worth mentioning to a neurologist, not just an eye doctor.